← FDA DRUG APPROVALS

FDA ANDA · ANDA077636

ZONISAMIDE

Sponsor: GRANULES

APPLICATION
ANDA077636
TYPE
ANDA
ORIGINAL APPROVAL
2005-12-22
LATEST ACTION
2023-03-08
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

ZONISAMIDEPrescription
ZONISAMIDE 50MG · CAPSULE · ORAL
ZONISAMIDEPrescription
ZONISAMIDE 25MG · CAPSULE · ORAL
ZONISAMIDEPrescription
ZONISAMIDE 100MG · CAPSULE · ORAL

Approval history

2023-03-08Labeling · Supplement 5 · standardAP
2023-03-08Labeling · Supplement 6 · standardAP
2010-08-13REMS · Supplement 3AP
2006-07-27Labeling · Supplement 2AP
2006-07-27Manufacturing (CMC) · Supplement 1AP
2005-12-22Original — Healthcare Professional Sheet ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →